EcoDrugPlus

Cyclin Dependent Kinase 4

Ensembl ID : ENSCAFG00020022861
Gene Symbol: CDK4
2 Cross references
225 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSCAFG00020006340
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSCAFG00020011877
Gene Symbol: CDK6
1 Cross references
201 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSCAFG00020019263
Gene Symbol: CDK7
3 Cross references
219 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSCAFG00020015789
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSCAFG00020024986
Gene Symbol: CYSLTR1
3 Cross references
181 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSCAFG00020008511
Gene Symbol: CDA
3 Cross references
232 Possible Orthologues:

Cytochrome P450 3a12

Ensembl ID : ENSCAFG00020014437
Gene Symbol: LOC112646266
2 Cross references
690 Possible Orthologues:

Cytochrome P450 3a12

Ensembl ID : ENSCAFG00020014417
Gene Symbol: LOC112646266
2 Cross references
690 Possible Orthologues:

Cytochrome P450 3a12-Like

Ensembl ID : ENSCAFG00020014350
Gene Symbol: LOC112646264
2 Cross references
682 Possible Orthologues:

Cytochrome P450 3a12-Like

Ensembl ID : ENSCAFG00020015253
Gene Symbol: LOC112663048
2 Cross references
690 Possible Orthologues:

Cytochrome P450 3a12-Like

Ensembl ID : ENSCAFG00020014292
Gene Symbol: LOC112646265
2 Cross references
681 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).